Search
Halozyme Therapeutics Inc
HALOAdd to Watchlist
130.340USD
+1.720+1.34%
Close 11-04 16:00（ET）
14.79BMarket Cap
44.07P/E TTM
Pre-market 07:06 (ET)132.300USD+1.960+1.50%
Pre-market 07:06 (ET)Today
+1.34%
5 Days
+0.24%
1 Month
+18.64%
6 Months
+101.86%
Year to Date
+93.67%
1 Year
+91.54%
Key Figures
130.810Open
130.980High
101.71KVolume
44.07P/E TTM
11.70P/E Dynamic
--Dividend TTM
0.09%Turnover Ratio
128.620Prev. Close
126.860Low
13.14MTurnover
33.29P/E Static
103.00P/B
0.00%Div Yield TTM
14.33%ROA
134.00052wk High
0.05Volume Ratio
444.09MNet Profit
113.50MShares
2.9559EPS TTM
0.88Beta
99.40%ROE
61.23052wk Low
3.48%Amplitude
77.40%Gross Margin
14.79BMarket Cap
14.15Reward/Risk
2.36%Risk Rate
Halozyme Therapeutics Inc's Score
0.16vs previous score
Forecast7.80
Financial Health8.36
Technical5.67
Valuation Dimensions9.17
Institutional Confidence10.00
Risk Assessment7.62
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Halozyme Therapeutics Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
1.96/1.84
Revenue / Forecast
481.00M/407.49M
Halozyme Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolHALO
Number of employees350
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 9.73% |
| Vanguard Capital Management, LLC | 4.44% |
| Vanguard Portfolio Management, LLC | 4.43% |
| State Street Investment Management (US) | 4.32% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 52.12% |
| Investment Advisor/Hedge Fund | 38.27% |
| Research Firm | 5.24% |
| Hedge Fund | 5.07% |
Related Instruments
+0.61%
+3.81%
+3.09%
+3.93%
+3.59%
+2.79%
+3.73%
+4.19%
+4.95%
+2.63%
+3.44%
+4.02%
+6.98%
+4.72%
+13.11%
+5.03%
-4.39%
+1.49%
+3.55%
+3.36%Popular Instruments
53752.400
+387.800 (+0.73%)
28218.800
-215.100 (-0.76%)
7700.100
+7.700 (+0.10%)
12797.000
-1.000 (-0.01%)
60977.000
-2044.000 (-3.24%)
6301.100
-4.800 (-0.08%)
88.815
+0.774 (+0.88%)
349.510
+17.610 (+5.31%)
200.130
-6.560 (-3.17%)
4123.640
+59.700 (+1.47%)
FAQs
What is the current price of Halozyme Therapeutics Inc (HALO)?
The current price of Halozyme Therapeutics Inc (HALO) is 130.34.
What is the symbol of Halozyme Therapeutics Inc?
The ticker symbol of Halozyme Therapeutics Inc is HALO.
What is the 52-week high of Halozyme Therapeutics Inc?
The 52-week high of Halozyme Therapeutics Inc is 134.00.
What is the 52-week low of Halozyme Therapeutics Inc?
The 52-week low of Halozyme Therapeutics Inc is 61.23.
What is the market capitalization of Halozyme Therapeutics Inc?
The market capitalization of Halozyme Therapeutics Inc is 14.79B.
Is Halozyme Therapeutics Inc (HALO) currently rated as Buy, Hold, or Sell?
According to analysts, Halozyme Therapeutics Inc (HALO) has an overall rating of Buy, with a price target of 108.83.
What is the Earnings Per Share (EPS TTM) of Halozyme Therapeutics Inc (HALO)?
The Earnings Per Share (EPS TTM) of Halozyme Therapeutics Inc (HALO) is 2.96.